V006-0185 Screening compound: 3,3-dimethyl-N-(4-{4-oxo-3-[4-(propan-2-yl)phenyl]-1,3-thiazolidin-2-yl}phenyl)butanamide

V006-0185 Screening compound: 3,3-dimethyl-N-(4-{4-oxo-3-[4-(propan-2-yl)phenyl]-1,3-thiazolidin-2-yl}phenyl)butanamide
V006-0185 Screening compound: 3,3-dimethyl-N-(4-{4-oxo-3-[4-(propan-2-yl)phenyl]-1,3-thiazolidin-2-yl}phenyl)butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V006-0185
3,3-dimethyl-N-(4-{4-oxo-3-[4-(propan-2-yl)phenyl]-1,3-thiazolidin-2-yl}phenyl)butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V006-0185

Molecular Formula

C24H30N2O2S (C24 H30 N2 O2 S)

Compound Name

3,3-dimethyl-N-(4-{4-oxo-3-[4-(propan-2-yl)phenyl]-1,3-thiazolidin-2-yl}phenyl)butanamide

IUPAC name

33-dimethyl-N-(4-{4-oxo-3-[4-(propan-2-yl)phenyl]-13-thiazolidin-2-yl}phenyl)butanamide

SMILES

CC(C)c(cc1)ccc1N(C(c(cc1)ccc1NC(CC(C)(C)C)=O)SC1)C1=O

InChI

InChI=1S/C24H30N2O2S/c1-16(2)17-8-12-20(13-9-17)26-22(28)15-29-23(26)18-6-10-19(11-7-18)25-21(27)14-24(3,4)5/h6-13,16,23H,14-15H2,1-5H3,(H,25,27)/t23-/m0/s1

InChI Key

OZNYDWBVSLAMTJ-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD19854990

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

410.58

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

5.658

Distribution Coefficient, logD

5.658

Water Solubility, LogSw

-5.43

Polar Surface Area

39.282

Acid Dissociation Constant (pKa)

12.01

Base Dissociation Constant (pKb)

2.32

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

41.70

V006-0185 in Drug Discovery

Included in Screening Libraries

Cardiovascular Library (22201 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cardiovascular
  • Cancer
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V006-0185 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V006-0185?
Check Price and Availability of V006-0185, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V006-0185 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V006-0185
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V006-0185
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V006-0185 available by request